Teza Capital Management LLC Takes $208,000 Position in Align Technology, Inc. $ALGN

Teza Capital Management LLC purchased a new stake in Align Technology, Inc. (NASDAQ:ALGN) in the first quarter, according to its most recent filing with the SEC. The fund purchased 1,311 shares of the medical equipment provider’s stock, valued at approximately $208,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Orion Capital Management LLC bought a new position in Align Technology during the 4th quarter worth $42,000. Compagnie Lombard Odier SCmA bought a new position in Align Technology during the 1st quarter worth $32,000. Center for Financial Planning Inc. bought a new position in Align Technology during the 1st quarter worth $35,000. SVB Wealth LLC bought a new position in Align Technology during the 1st quarter worth $36,000. Finally, Mather Group LLC. grew its stake in Align Technology by 375.0% during the 1st quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 345 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors.

Align Technology Stock Down 0.7%

Shares of Align Technology stock opened at $135.93 on Wednesday. The firm has a market cap of $9.85 billion, a price-to-earnings ratio of 22.92, a price-to-earnings-growth ratio of 1.54 and a beta of 1.65. The business has a fifty day simple moving average of $164.43 and a 200-day simple moving average of $171.20. Align Technology, Inc. has a fifty-two week low of $127.70 and a fifty-two week high of $262.87.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The company’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. Analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has authorized a stock buyback plan on Tuesday, August 5th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to reacquire up to 2% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

ALGN has been the subject of a number of recent research reports. Morgan Stanley restated an “equal weight” rating and set a $154.00 price objective (down from $249.00) on shares of Align Technology in a research note on Thursday, July 31st. Evercore ISI boosted their price target on Align Technology from $200.00 to $220.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 9th. Piper Sandler decreased their price target on Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Wells Fargo & Company decreased their price target on Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Finally, Stifel Nicolaus decreased their price target on Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research note on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Align Technology presently has an average rating of “Moderate Buy” and an average price target of $215.00.

Insider Buying and Selling at Align Technology

In other news, CEO Joseph M. Hogan acquired 7,576 shares of the business’s stock in a transaction dated Friday, August 1st. The stock was acquired at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the acquisition, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This represents a 4.27% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 0.66% of the stock is currently owned by company insiders.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.